: iStockAnalyst.com Symbols Feed

Gilead (GILD): 4-in-1 HIV drug

Tue, 03 Nov 2009 15:16:46 GMT

"Gilead Sciences (NASDAQ: GILD) develops treatments for life-threatening diseases and specializes in drugs for HIV, the virus that causes AIDS," notes Hannah Choe.[More...]

Insider Buys And Sells: Weekly Wrap-up (10/19/2009)

Mon, 19 Oct 2009 13:37:06 GMT

For all the analysts and pundits in the financial media, there is still no better judge of a company's health and future prospects than the owners and executives of those companies themselves, along with major institutional shareholders.[More...]

Gilead (GILD): 'A Stock For All Seasons'

Wed, 30 Sep 2009 13:43:10 GMT

"Gilead Sciences (NASDAQ: GILD), one of the world's largest biotechs, is a stock for all seasons," say growth expert Alexander Green.[More...]

Swine Flu Helping Gilead Sciences(GILD), GlaxoSmithKline (GSK)

Mon, 28 Sep 2009 16:15:00 GMT

The Severe Acute Respiratory Syndrome (SARS) outbreak in 2003 is still fresh in our memories.[More...]

15 Stocks Having ATough Quarter But Worth A Look

Mon, 21 Sep 2009 05:06:38 GMT

The S&P 500 ended moved into the green in May and has never looked back. So far in Q3, it's up a whopping 16.8%, even better than Q2's 15.9% total return. Despite the large advance, 40 of the members are actually down QTD. Thinking that there might be some opportunities from the long side, I wanted to take a closer look, so I created a screen in StockVal to narrow the list. Here is how I constrained the group:[More...]

Swine Flu H1N1, What Makes This Flu Scary (SVA, GLID, GSK, NVS)

Wed, 16 Sep 2009 17:24:00 GMT

Swine Flu, officially known as N1H1 influenza , is having a far reaching effect on every one of us. The virus was first tracked in a small town in Mexico in May of 2009 and has spread to nearly every part of the world.[More...]

Insider Buys And Sells: Weekly Wrap-Up

Mon, 14 Sep 2009 17:02:02 GMT

Taping Profits Of Swine Flu With Tamiflu: GILD

Thu, 10 Sep 2009 15:28:54 GMT

Flu season is approaching quickly and fresh fears over a possible H1N1 epidemic have taken hold. Hospitals and pharmacies are stocking up on medications to counter such an outbreak, and the most popular drug to treat flu is Tamiflu.[More...]

Insider Buys and Sells: Weekly Wrap-up - 09-08-2009

Tue, 08 Sep 2009 12:56:44 GMT

Gilead Sciences Stock Review (GILD)

Fri, 04 Sep 2009 16:20:30 GMT

Gilead Sciences (GILD) is a good bio-technology companies with their strong franchise in HIV, a growing franchise in Hepatitis and potential in cardio-vascular therapies. Many think of Gilead as the provider of Tamiflu, a therapy for influenza. However, Tamiflu is a small part of the story and it has limited impact on the company’s prospects.[More...]

Silicon Valley Stocks: Dow, Nasdaq, Symantec, LSI Climb

Fri, 30 Oct 2009 16:50:00 GMT

Oct. 30--Silicon Valley tech stocks, the Dow and the Nasdaq were higher today after the government's better-than-expected report on economic growth cheered investors on Wall Street.
Apple, Google, Cisco Systems, Hewlett-Packard, Intel, Oracle, Gilead Sciences, eBay, Yahoo, Adobe Systems and most Silicon Valley tech stocks were higher.
The blue chip Dow Jones industrial average, which includes Cisco, HP and Intel, climbed 199.89, or 2.05 percent, to 9,962.58.

: iStockAnalyst.com Symbols Feed

Gilead (GILD): 4-in-1 HIV drug

Insider Buys And Sells: Weekly Wrap-up (10/19/2009)

Gilead (GILD): 'A Stock For All Seasons'

Swine Flu Helping Gilead Sciences(GILD), GlaxoSmithKline (GSK)

15 Stocks Having ATough Quarter But Worth A Look

Swine Flu H1N1, What Makes This Flu Scary (SVA, GLID, GSK, NVS)

Insider Buys And Sells: Weekly Wrap-Up

Taping Profits Of Swine Flu With Tamiflu: GILD

Insider Buys and Sells: Weekly Wrap-up - 09-08-2009

Gilead Sciences Stock Review (GILD)

Silicon Valley Stocks: Dow, Nasdaq, Symantec, LSI Climb

Silicon Valley Stocks: Tech Shares Slide; Nasdaq Falls 2.7 Percent

Silicon Valley Stocks: 'Phenomenal' Earnings Boost Google; AMD Slides

Silicon Valley Stocks: Nasdaq Rises, but Yahoo Shares Sink 4 Percent

Silicon Valley Tech Stocks Rise on Encouraging Economic News

Most Big Silicon Valley Stocks Fall; Upgrades Lift Apple, Intel, VMware

Analyst Picks and Pans: Las Vegas Sands, Gilead, Intl. Paper

Stocks: Finding Long-Term Winners

Achillion Wins New US Patent

PSEG Names New Executive VP/CFO

Achillion Reports Third Quarter Results

Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter

Stocks This Morning: Dragon Capital Group - August 26, 2009

StockPreacher.com Issues Trading Outlook for Cell Therapeutics Inc.

Gilead Announces Senior Management Promotion

EFI Reports Q2 2009 Results

Kevin E. Lofton Joins Gilead Sciences’ Board of Directors

Gilead Sciences Announces Record Second Quarter 2009 Financial Results

Landmark Five-Year African Study Indicates That HIV Therapy May Be Given Safely in Resource-Limited Settings Without Routine Laboratory Monitoring

Gilead Sciences Announces Agreement With Tibotec Pharmaceuticals to Develop and Commercialize New Fixed-Dose Combination of Truvada® and TMC278

Form 4 Metza Kristen For: Nov 04 (10K)

Form 4 Alton Gregg H For: Nov 02 (10K)

Form 4 GILEAD SCIENCES INC For: Oct 29 Filed by: BERG PAUL (10K)

Form 4 MARTIN JOHN C For: Oct 13 (10K)

Form 4 YOUNG KEVIN For: Oct 05 (10K)

Form 4 Alton Gregg H For: Oct 01 (10K)

Form 4 GILEAD SCIENCES INC For: Sep 24 Filed by: BERG PAUL (10K)

Form 4 MARTIN JOHN C For: Sep 08 (10K)

Form 4 MILLIGAN JOHN F For: Sep 01 (10K)

Form 4 Alton Gregg H For: Sep 01 (10K)